A recently released analysis report from the Deloitte Center for Government Insights that examines the US’s current and proposed software as a medical device (SaMD) regulatory landscape, and includes suggestions on how the FDA’s pre-certification pilot program and other initiatives could better serve this fast-moving industry.

http://www.mobihealthnews.com/content/deloitte-report-offers-guidance-fdas-upcoming-software-regulation-pathway